Group 1 - The core viewpoint of the news is that China Ping An Insurance has increased its stake in China Pacific Insurance, indicating a trend of "insurance companies buying insurance" and reflecting a strategic shift towards high-dividend asset allocation [1][2] - China Ping An acquired approximately 1.74 million shares of China Pacific Insurance at a price of HKD 32.07 per share, totaling around HKD 55.84 million, resulting in a 5.04% ownership stake that triggered a regulatory notice [1] - The investment is characterized as a financial investment, aligning with the trend of insurance stocks being redefined as "alternative dividend assets," with China Pacific Insurance's current dividend yield at 3.5%, significantly higher than long-term bond yields [2] Group 2 - The report from Guosen Securities highlights that the increase in stake signals a medium to long-term valuation recovery potential for insurance stocks, with China Pacific Insurance's H-shares having risen 42.4% since 2025 and a current P/EV ratio of 0.73 [2] - The investment reflects a broader trend in the industry where insurance companies are increasingly viewing their peers as viable investment opportunities, as evidenced by a similar case in 2019 when China Life Insurance increased its stake in China Pacific Insurance [2]

Core Viewpoint - China Ping An Life Insurance Co., Ltd. has disclosed information regarding its investment in China Life Insurance Co., Ltd. H-shares, which has triggered a mandatory disclosure due to reaching a 5% stake in the company [1][2]. Group 1: Basic Information - Stock Name and Code: China Life (2628.HK) [1] - Transaction Date: August 13, 2025, when Ping An Asset Management Co., Ltd. reached a 5% stake in China Life H-shares [1]. - Announcement Date: August 18, 2025, as per Hong Kong Securities and Futures Ordinance [2]. Group 2: Company Financials - As of March 31, 2025, the total assets of the company were CNY 5,383.19 billion, net assets were CNY 358.04 billion, and the comprehensive solvency adequacy ratio was 227.92% [3]. Group 3: Investment Details - The book balance of the investment in China Life H-shares as of August 13, 2025, was CNY 7.993 billion, representing 0.14% of the total assets as of the previous quarter [7]. - The book balance of equity assets as of March 31, 2025, was CNY 1,097.2 billion, accounting for 23.26% of total assets [9]. Group 4: Transaction Method and Funding - The shares were purchased through a competitive bidding process [11]. - The funding for this investment came from the company's insurance liability reserves [12]. Group 5: Management and Reporting - The investment is managed through a delegated investment approach [12]. - The company will report to the National Financial Regulatory Administration as per relevant regulations [12].

Core Business Performance - Total revenue for the first half of 2025 reached RMB2.5 billion, marking a 19.5% year-on-year increase, while net profit attributable to shareholders rose to RMB134 million, a significant increase of 136.8% year-on-year [1] - Revenue from the integrated finance business and corporate health management business increased by 30.2% year-on-year, with the total number of paying users growing by 35.1% year-on-year [1] Synergistic Model and Corporate Health Management - The company has deepened its "insurance + health care" synergistic model, enhancing collaboration with Ping An Group's integrated finance business, which has expanded its corporate customer base and improved profit quality [2] - The number of B-end paying corporate clients exceeded 3,500, with B-end paying users surpassing 3.60 million, reflecting a 39.2% year-on-year increase [4] Service Expansion and User Engagement - The company provided one-stop, 24/7 medical and senior care services to Ping An Group's retail integrated financial customers, achieving a 34.6% year-on-year increase in F-end paying users to approximately 20.0 million [3] - The family doctor membership grew to over 35 million, with home-based senior care service users increasing by approximately 83% year-on-year [7] AI-Powered Healthcare Applications - The company enhanced its capabilities in AI-driven healthcare services, introducing the "7+N+1" AI medical product system, which includes various AI applications for intelligent decision support [9] - AI-assisted consultations achieved an accuracy rate of approximately 98%, while the average service cost per family doctor user was reduced by about 52% [9] Strategic Focus and Future Outlook - The company aims to become the most professional "family doctor and senior care concierge," focusing on customer needs and sustainable value creation for shareholders and society [10]

证券代码：601318 证券简称：中国平安 公告编号：临 2025-030 中国平安保险（集团）股份有限公司 关于召开 2025 年中期业绩发布会的公告 投资者可于 2025 年 8 月 22 日（星期五）23:59 前将相关问题通过电子邮件 的形式发送至本公司投资者关系邮箱：IR@pingan.com.cn。本公司将会于 2025 年中期业绩发布会（以下简称"业绩发布会"）上对投资者普遍关注的问题进行 回答。 一、业绩发布会类型 本公司拟于 2025 年 8 月 27 日在上海证券交易所网站（www.sse.com.cn）披 露本公司 2025 年中期报告。为了便于广大投资者更全面深入地了解本公司 2025 年中期业绩和经营情况，本公司拟于 2025 年 8 月 27 日中午 11:45-12:45 召开业 绩发布会，并对投资者普遍关注的问题进行回答。 二、业绩发布会召开的时间、地点 重要内容提示： 中国平安保险（集团）股份有限公司（以下简称"本公司"）董事会及全体董事 保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 （ 三 ） 网 络 直 播 ...

中国平安保险（集团）股份有限公司 关于 2025 年度长期服务计划实施进展的公告 中国平安保险（集团）股份有限公司（以下简称"本公司"）董事会及全体董事 保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 本公司第十三届董事会第七次会议审议通过了《关于审议 2025 年度长期服 务计划参与情况的议案》（以下简称"2025 年度长期服务计划"）。 现将本公司 2025 年度长期服务计划的实施进展公告如下： 截至本公告日期，本公司 2025 年度长期服务计划暂无实施进展。本公司将 根据后续情况及时履行信息披露义务。 特此公告。 中国平安保险（集团）股份有限公司董事会 证券代码：601318 证券简称：中国平安 公告编号：临 2025-031 2025 年 8 月 19 日 ...

中国平安（601318）(02318)发布公告，截至本公告日期，本公司2025年度长期服务计划暂无实施进 展。本公司将根据后续情况及时履行信息披露义务。 ...

智通财经APP讯，中国平安(02318)发布公告，截至本公告日期，本公司2025年度长期服务计划暂无实施 进展。本公司将根据后续情况及时履行信息披露义务。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 自願性公告 2025年度長期服務計劃實施進展 中國平安保險（集團）股份有限公司（「本公司」）第十三屆董事會（「董 事會」）第七次會議審議通過了《關於審議2025年度長期服務計劃參與情況 的議案》（「2025年度長期服務計劃」）。 現將本公司2025年度長期服務計劃的實施進展公告如下： 截至本公告日期，本公司2025年度長期服務計劃暫無實施進展。本公司將根 據後續情況及時履行信息披露義務。 承董事會命 盛瑞生 公司秘書 中國深圳，2025年8月19日 於本公告日期，本公司的執行董事為馬明哲、謝永林、郭曉濤、付欣及蔡方方；非執 行董事為謝吉人、楊小平、何建鋒及蔡潯；獨立非執行董事為伍成業、儲一昀、劉宏、 吳港平、金李及王廣謙。 ...

【导读】中国平安增持农业银行及中国人寿H股！ 险资继续狂买银行、保险H股！ 8月19日，据香港联交所股权披露，中国平安（601318）保险（集团）股份有限公司（以下简称中国平 安）旗下平安人寿举牌农业银行（601288）H股和中国人寿（601628）H股，累计耗资约4.65亿港元。 累计斥资4.65亿港元增持 披露公告显示，在8月13日，平安人寿以5.5041港元每股的平均价买入2651.5万股农业银行H股，耗资约 1.46亿港元，交易后平安人寿持有农业银行H股比例由13.99%增至14.08%。 值得一提的是，同日，平安人寿还增持了中国人寿保险股份有限公司（以下简称中国人寿）H股，其以 22.7439港元每股的平均价格买入1406.7万股中国人寿H股，耗资约3.19亿港元。交易完成后，平安人寿 对中国人寿H股持股比例由原来的4.99%升至5.18%。 据悉，在8月18日，平安人寿还披露了其此前于8月11日举牌中国太平洋保险（集团）股份有限公司（以 下简称中国太保（601601））H股情况，增持后，其持股比例由原来的4.97%升至5.1%。同时，这也是 时隔六年再次出现险资举牌险企的情况。 此外，在8月12日 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 召開2025年中期業績發佈會 中國平安保險（集團）股份有限公司（「本公司」）擬於2025年8月26日在香港聯合交易所有限公 司網站（www.hkexnews.hk）公佈本公司2025年中期業績。為了便於廣大投資者更深入、全面地 瞭解本公司2025年中期業績和經營情況，本公司擬於2025年8月27日中午11:45-12:45通過網路直播 方式召開2025年中期業績發佈會（「業績發佈會」）。本公司董事長馬明哲、總經理兼聯席首席 執行官謝永林、聯席首席執行官郭曉濤、副總經理兼首席財務官（財務負責人）付欣、公司秘書 盛瑞生以及獨立非執行董事將出席業績發佈會。投資者屆時可登陸全景網（www.p5w.net）和上 證路演中心（http://roadshow.sseinfo.com）觀看業績發佈會。 投資者可於2025年8月22日23:59前將相關問題通過電子郵件的形式發送至本公司投資者關係郵 箱：IR@pingan ...